US Stock MarketDetailed Quotes

PBM Psyence Biomedical

Watchlist
  • 3.460
  • -0.050-1.42%
Close Nov 29 13:00 ET
  • 3.540
  • +0.080+2.31%
Post 17:01 ET
2.92MMarket Cap-12P/E (TTM)

Psyence Biomedical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Mar 31, 2024
(FY)Mar 31, 2023
(FY)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-85.00%-2.95M
-14.01%-1.59M
-1.4M
Net income from continuing operations
-1,495.53%-51.16M
-72.55%-3.21M
---1.86M
Operating gains losses
133.62%28.41K
---84.5K
----
Depreciation and amortization
--240
--0
----
Other non cash items
--43.58M
----
----
Change In working capital
-179.39%-1.17M
1,038.80%1.48M
--129.74K
-Change in receivables
197.96%107.62K
-209.80%-109.86K
--100.05K
-Change in prepaid assets
-241.97%-245.08K
-56,019.30%-71.67K
--128.1579
-Change in payables and accrued expense
-162.41%-1.04M
5,511.67%1.66M
--29.56K
Cash from discontinued investing activities
Operating cash flow
-85.00%-2.95M
-14.01%-1.59M
---1.4M
Investing cash flow
Cash flow from continuing investing activities
-5.73K
0
-32.04K
Net PPE purchase and sale
---5.73K
--0
----
Net other investing changes
----
----
---32.04K
Cash from discontinued investing activities
Investing cash flow
---5.73K
--0
---32.04K
Financing cash flow
Cash flow from continuing financing activities
100.35%2.35M
172.07%1.17M
-1.63M
Net issuance payments of debt
--2.35M
--0
----
Net other financing activities
----
172.07%1.17M
---1.63M
Cash from discontinued financing activities
Financing cash flow
100.35%2.35M
172.07%1.17M
---1.63M
Net cash flow
Beginning cash position
-23.90%1.33M
-63.55%1.75M
--4.81M
Current changes in cash
-43.40%-601.09K
86.28%-419.16K
---3.06M
End cash Position
-45.05%733.19K
-23.97%1.33M
--1.76M
Free cash flow
-85.36%-2.95M
-14.01%-1.59M
---1.4M
Currency Unit
USD
USD
USD
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
(FY)Mar 31, 2024 (FY)Mar 31, 2023 (FY)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -85.00%-2.95M -14.01%-1.59M -1.4M
Net income from continuing operations -1,495.53%-51.16M -72.55%-3.21M ---1.86M
Operating gains losses 133.62%28.41K ---84.5K ----
Depreciation and amortization --240 --0 ----
Other non cash items --43.58M ---- ----
Change In working capital -179.39%-1.17M 1,038.80%1.48M --129.74K
-Change in receivables 197.96%107.62K -209.80%-109.86K --100.05K
-Change in prepaid assets -241.97%-245.08K -56,019.30%-71.67K --128.1579
-Change in payables and accrued expense -162.41%-1.04M 5,511.67%1.66M --29.56K
Cash from discontinued investing activities
Operating cash flow -85.00%-2.95M -14.01%-1.59M ---1.4M
Investing cash flow
Cash flow from continuing investing activities -5.73K 0 -32.04K
Net PPE purchase and sale ---5.73K --0 ----
Net other investing changes ---- ---- ---32.04K
Cash from discontinued investing activities
Investing cash flow ---5.73K --0 ---32.04K
Financing cash flow
Cash flow from continuing financing activities 100.35%2.35M 172.07%1.17M -1.63M
Net issuance payments of debt --2.35M --0 ----
Net other financing activities ---- 172.07%1.17M ---1.63M
Cash from discontinued financing activities
Financing cash flow 100.35%2.35M 172.07%1.17M ---1.63M
Net cash flow
Beginning cash position -23.90%1.33M -63.55%1.75M --4.81M
Current changes in cash -43.40%-601.09K 86.28%-419.16K ---3.06M
End cash Position -45.05%733.19K -23.97%1.33M --1.76M
Free cash flow -85.36%-2.95M -14.01%-1.59M ---1.4M
Currency Unit USD USD USD
Audit Opinions Unqualified Opinion with Explanatory Notes -- --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data